CD274 and ovarian carcinoma: In ovarian cancer, where soluble PD-1 remains less studied than soluble PD-L1, existing data suggest that soluble checkpoint ligands in peritoneal fluid correlate with immune regulation, CA125 levels, and clinical outcomes, underscoring that our soluble PD-1 findings are preliminary and should be further investigated with a dedicated study [33].